TransCode Therapeutics, Inc. RNAZ

Set alert

Price alert · RNAZ

All alert types
1.62 USD -0.01 -0.61%

As of Nov 2, 2:13 PM ET

Bid
1.62 × 2
Ask
1.65 × 1
1.61 Day range 1.69
1.52 52-week range 12.60
YTD
-76.28%
1 year
-85.54%
Open
1.69
Prev close
1.63
Mkt cap
27.43M
Vol
12.17K
Avg vol
53.82K
EPS
-52.06
P/E
0.00
Div yield
0.00%
More statistics
Low
1.61
High
1.69
Forward P/E
-5.97
Beta
0.65
Short ratio
0.50
Inst. own
1.99%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
13.50
200-d avg
20.41
1y target
20.00

MAX chart

Chart tools
Interval

Chart is warming up

The all-time price history for RNAZ has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.94 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

0 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -0.1×
FY 2018: -1160×FY 2019: -38017×FY 2020: -9318×FY 2021: -2028×FY 2022: -4.8×FY 2023: -1.2×FY 2024: -1.4×FY 2025: -0.1×
FY 2018 5y median -1.4× FY 2025
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.5×
FY 2018: -1043×FY 2019: -15979×FY 2020: -6408×FY 2021: 678×FY 2022: 1743×FY 2023: 14.1×FY 2024: -11.7×FY 2025: 0.5×
FY 2018 5y median 14.1× FY 2025
P/FCF -0.2×
FY 2018: -1754×FY 2019: -34488×FY 2020: -44304×FY 2021: -2507×FY 2022: -356×FY 2023: -1.3×FY 2024: -1.8×FY 2025: -0.2×
FY 2018 5y median -1.8× FY 2025
EV/EBITDA 0.4×
FY 2018: 0.0×FY 2019: -38953×FY 2020: -11205×FY 2021: -2061×FY 2022: -323×FY 2023: -1.2×FY 2024: -1.1×FY 2025: 0.4×
FY 2018 5y median -1.2× FY 2025
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -414.4%
FY 2018: -0.1%FY 2019: -0.0%FY 2020: -0.0%FY 2021: -0.0%FY 2022: -0.3%FY 2023: -78.3%FY 2024: -56.8%FY 2025: -414.4%
FY 2018 5y median -56.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -335.4%
FY 2018: 90.0%FY 2019: 55.3%FY 2020: 68.8%FY 2021: -33.5%FY 2022: -542.0%FY 2023: -1130.3%FY 2024: 830.0%FY 2025: -335.4%
FY 2018 5y median -335.4% FY 2025
ROIC -17.6%
FY 2018: -289.5%FY 2019: -297.1%FY 2020: -111.7%FY 2021: -30.1%FY 2022: -576.0%FY 2023: -928.5%FY 2024: -343.4%FY 2025: -17.6%
FY 2018 5y median -343.4% FY 2025
ROA -21.3%
FY 2018: -211.3%FY 2019: -280.2%FY 2020: -222.1%FY 2021: -29.8%FY 2022: -231.5%FY 2023: -358.7%FY 2024: -229.7%FY 2025: -21.3%
FY 2018 5y median -229.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income -78.7%
FY 2018: 0.0%FY 2019: -19.0%FY 2020: -59.0%FY 2021: -746.6%FY 2022: -203.5%FY 2023: -4.0%FY 2024: 19.4%FY 2025: -78.7%
FY 2018 FY 2025
EPS (diluted) -11.6%
FY 2018: 0.0%FY 2019: 96.9%FY 2020: -308.0%FY 2021: -120.6%FY 2022: -66.7%FY 2023: -219.8%FY 2024: 98.6%FY 2025: -11.6%
FY 2018 FY 2025
Free Cash Flow -46.2%
FY 2018: 0.0%FY 2019: -69.7%FY 2020: 3.1%FY 2021: -1020.1%FY 2022: -187.3%FY 2023: -14.2%FY 2024: 26.2%FY 2025: -46.2%
FY 2018 FY 2025

Financial Health

Current Ratio 6.3×
FY 2018: 1.8×FY 2019: 3.2×FY 2020: 2.1×FY 2021: 9.0×FY 2022: 1.7×FY 2023: 1.3×FY 2024: 2.6×FY 2025: 6.3×
FY 2018 5y median 2.6× FY 2025
Quick Ratio 6.3×
FY 2018: 1.8×FY 2019: 3.2×FY 2020: 2.1×FY 2021: 9.0×FY 2022: 1.7×FY 2023: 1.3×FY 2024: 2.6×FY 2025: 6.3×
FY 2018 5y median 2.6× FY 2025
Debt / Equity 0.0×
FY 2018: -0.9×FY 2019: -0.8×FY 2020: -0.6×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: -0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2018: 0.0×FY 2019: -1.6×FY 2020: -0.6×FY 2021: 3.1×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.4×FY 2025: 0.5×
FY 2018 5y median 0.4× FY 2025
Interest Coverage -4229×
FY 2018: 0.0×FY 2019: -2.9×FY 2020: -1.8×FY 2021: -64.7×FY 2022: -1.1×FY 2023: -347×FY 2024: -584×FY 2025: -4229×
FY 2018 5y median -347× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31